SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness

In order to support vaccine development, and to aid convalescent plasma therapy, it would be important to understand the kinetics, timing and persistence of SARS-CoV-2 neutralizing antibodies (NAbs), and their association with clinical disease severity. Therefore, we used a surrogate viral neutraliz...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Jeewandara, Chandima, Jayathilaka, Deshni, Gomes, Laksiri, Wijewickrama, Ananda, Narangoda, Eranga, Idampitiya, Damayanthi, Guruge, Dinuka, Wijayamuni, Ruwan, Manilgama, Suranga, Ogg, Graham S., Tan, Chee Wah, Wang, Lin-Fa, Malavige, Gathsaurie Neelika
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7819970/
https://ncbi.nlm.nih.gov/pubmed/33479465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-81629-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados